Virosome-like vesicles comprising gp41-derived antigens

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9216156
APP PUB NO 20090202622A1
SERIAL NO

12281256

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to a virosome-like vesicle comprising at least a gp41-derived antigen or an analogue thereof, said gp41-derived antigen being located to the external surface of and/or encapsulated inside said vesicle and being in a convenient configuration for conferring said virosome-like vesicle with an ability to induce an immune response against a gp41 protein or a human immunodeficiency virus (HIV).

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
MYMETICS CORPORATION230 PARK AVENUE - SUITE 1000 NEW YORK NY 10169 USA
PEVION BIOTECH LTDREHHAGSTRASSE 79 CH-3018 BEM
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)75013 PARIS

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bomsel, Morgane Paris, FR 10 53
Fleury, Sylvain Bottens, CH 7 51
Zurbriggen, Rinaldo Schmitten, CH 15 165

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jun 22, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00